Logo image of OCGN

OCUGEN INC (OCGN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:OCGN - US67577C1053 - Common Stock

1.88 USD
-0.03 (-1.57%)
Last: 1/14/2026, 8:00:02 PM
1.8992 USD
+0.02 (+1.02%)
After Hours: 1/14/2026, 8:00:02 PM
Fundamental Rating

1

Taking everything into account, OCGN scores 1 out of 10 in our fundamental rating. OCGN was compared to 528 industry peers in the Biotechnology industry. OCGN may be in some trouble as it scores bad on both profitability and health. OCGN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year OCGN has reported negative net income.
  • In the past year OCGN has reported a negative cash flow from operations.
  • OCGN had negative earnings in each of the past 5 years.
  • OCGN had a negative operating cash flow in each of the past 5 years.
OCGN Yearly Net Income VS EBIT VS OCF VS FCFOCGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

  • OCGN has a Return On Assets of -111.15%. This is in the lower half of the industry: OCGN underperforms 77.46% of its industry peers.
  • OCGN has a Return On Equity of -1812.06%. This is amonst the worse of the industry: OCGN underperforms 80.68% of its industry peers.
Industry RankSector Rank
ROA -111.15%
ROE -1812.06%
ROIC N/A
ROA(3y)-79.4%
ROA(5y)-83.76%
ROE(3y)-144.88%
ROE(5y)-130.94%
ROIC(3y)N/A
ROIC(5y)N/A
OCGN Yearly ROA, ROE, ROICOCGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for OCGN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OCGN Yearly Profit, Operating, Gross MarginsOCGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20K -40K -60K -80K

More info and screens

1

2. Health

2.1 Basic Checks

  • OCGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, OCGN has more shares outstanding
  • Compared to 5 years ago, OCGN has more shares outstanding
  • OCGN has a worse debt/assets ratio than last year.
OCGN Yearly Shares OutstandingOCGN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
OCGN Yearly Total Debt VS Total AssetsOCGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • OCGN has an Altman-Z score of -5.84. This is a bad value and indicates that OCGN is not financially healthy and even has some risk of bankruptcy.
  • OCGN has a Altman-Z score of -5.84. This is in the lower half of the industry: OCGN underperforms 63.07% of its industry peers.
  • A Debt/Equity ratio of 8.04 is on the high side and indicates that OCGN has dependencies on debt financing.
  • OCGN has a worse Debt to Equity ratio (8.04) than 80.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 8.04
Debt/FCF N/A
Altman-Z -5.84
ROIC/WACCN/A
WACC8.69%
OCGN Yearly LT Debt VS Equity VS FCFOCGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

  • A Current Ratio of 1.85 indicates that OCGN should not have too much problems paying its short term obligations.
  • The Current ratio of OCGN (1.85) is worse than 77.65% of its industry peers.
  • A Quick Ratio of 1.85 indicates that OCGN should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.85, OCGN is doing worse than 75.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.85
OCGN Yearly Current Assets VS Current LiabilitesOCGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

  • OCGN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -29.41%.
  • OCGN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -48.07%.
EPS 1Y (TTM)-29.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40%
Revenue 1Y (TTM)-48.07%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%54.23%

3.2 Future

  • OCGN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 45.45% yearly.
  • The Revenue is expected to grow by 209.51% on average over the next years. This is a very strong growth
EPS Next Y-20.25%
EPS Next 2Y-13.98%
EPS Next 3Y21.92%
EPS Next 5Y45.45%
Revenue Next Year49.26%
Revenue Next 2Y-23.84%
Revenue Next 3Y230.39%
Revenue Next 5Y209.51%

3.3 Evolution

OCGN Yearly Revenue VS EstimatesOCGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1B 2B 3B
OCGN Yearly EPS VS EstimatesOCGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -50 -100

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • OCGN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OCGN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OCGN Price Earnings VS Forward Price EarningsOCGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OCGN Per share dataOCGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1 -0.15 -0.2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as OCGN's earnings are expected to grow with 21.92% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.98%
EPS Next 3Y21.92%

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for OCGN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

OCUGEN INC

NASDAQ:OCGN (1/14/2026, 8:00:02 PM)

After market: 1.8992 +0.02 (+1.02%)

1.88

-0.03 (-1.57%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-05
Earnings (Next)03-03
Inst Owners21.25%
Inst Owner Change0.03%
Ins Owners1.12%
Ins Owner Change48.73%
Market Cap587.16M
Revenue(TTM)5.37M
Net Income(TTM)-64.02M
Analysts81.82
Price Target9.18 (388.3%)
Short Float %19.18%
Short Ratio16.96
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.9%
Min EPS beat(2)-22.55%
Max EPS beat(2)14.75%
EPS beat(4)3
Avg EPS beat(4)3.39%
Min EPS beat(4)-22.55%
Max EPS beat(4)14.75%
EPS beat(8)7
Avg EPS beat(8)15.68%
EPS beat(12)9
Avg EPS beat(12)14.24%
EPS beat(16)10
Avg EPS beat(16)-204.99%
Revenue beat(2)2
Avg Revenue beat(2)248.45%
Min Revenue beat(2)212.3%
Max Revenue beat(2)284.59%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)38.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.35%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)98.46%
Revenue NY rev (1m)2.66%
Revenue NY rev (3m)54.31%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 109.34
P/FCF N/A
P/OCF N/A
P/B 166.19
P/tB 166.19
EV/EBITDA N/A
EPS(TTM)-0.22
EYN/A
EPS(NY)-0.25
Fwd EYN/A
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS0.02
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -111.15%
ROE -1812.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-79.4%
ROA(5y)-83.76%
ROE(3y)-144.88%
ROE(5y)-130.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 8.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4.82%
Cap/Sales 3.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 1.85
Altman-Z -5.84
F-Score1
WACC8.69%
ROIC/WACCN/A
Cap/Depr(3y)863.08%
Cap/Depr(5y)672.89%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40%
EPS Next Y-20.25%
EPS Next 2Y-13.98%
EPS Next 3Y21.92%
EPS Next 5Y45.45%
Revenue 1Y (TTM)-48.07%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%54.23%
Revenue Next Year49.26%
Revenue Next 2Y-23.84%
Revenue Next 3Y230.39%
Revenue Next 5Y209.51%
EBIT growth 1Y3.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y30.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.12%
OCF growth 3YN/A
OCF growth 5YN/A

OCUGEN INC / OCGN FAQ

What is the fundamental rating for OCGN stock?

ChartMill assigns a fundamental rating of 1 / 10 to OCGN.


What is the valuation status for OCGN stock?

ChartMill assigns a valuation rating of 1 / 10 to OCUGEN INC (OCGN). This can be considered as Overvalued.


What is the profitability of OCGN stock?

OCUGEN INC (OCGN) has a profitability rating of 0 / 10.


What is the financial health of OCUGEN INC (OCGN) stock?

The financial health rating of OCUGEN INC (OCGN) is 1 / 10.